Neuroblastoma Trials in Minneapolis, United States
Conditions / Neuroblastoma / Minneapolis, United States
Research into Neuroblastoma spans multiple therapeutic approaches and trial phases.
43 total trials for this combination
Showing top 10 of 43 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02176967 | Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00003119 | Surgery in Treating Children With Neuroblastoma | COMPLETED | PHASE3 |
| NCT00003093 | Combination Chemotherapy in Treating Children With Neuroblastoma | COMPLETED | PHASE3 |
| NCT00716976 | Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy | COMPLETED | PHASE3 |
| NCT00003234 | Vinorelbine in Treating Children With Recurrent or Refractory Cancers | COMPLETED | PHASE2 |
| NCT00006102 | Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | COMPLETED | PHASE2 |
| NCT06172296 | Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma | RECRUITING | — |
| NCT06172296 | Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma | RECRUITING | — |
| NCT00080873 | Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation | COMPLETED | NA |
| NCT00602446 | Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant | TERMINATED | PHASE2 |